Aditxt, Inc. filings document the company’s life sciences platform, its common stock capital structure, and material events affecting its operating subsidiaries and public-company status. Recent Form 8-K reports cover the completed acquisition of Ignite Proteomics, related financial statements and pro forma information, senior unsecured promissory notes, at-the-market offering capacity, and Nasdaq listing-compliance matters.
Proxy materials and meeting reports describe board elections, auditor ratification, executive-compensation votes, reverse stock split authority, and other stockholder matters. The filing record also includes disclosures on preferred stock issued in acquisition consideration, equity financing arrangements, governance approvals, and risks associated with maintaining exchange listing standards.
HRT Financial LP, a ten percent owner of Aditxt, Inc., reported both buying and selling common stock in close succession. On June 18, 2026, it made an open-market purchase of 7,340,178 shares at $0.013 per share. On June 22, 2026, it executed an open-market sale of 5,120,480 shares at $0.018 per share. Overall, the transactions represent a net purchase of 2,219,698 shares according to the filing’s transaction summary.
Aditxt, Inc. disclosed an initial ownership report showing that HRT Financial LP is a ten percent owner of the company’s common stock. The filing lists direct beneficial ownership of 2,406,438 shares of Common Stock
Aditxt, Inc. filed a Form 4 showing that reporting person Tai Wey Ann, identified as a ten percent owner, holds 100,000 shares of Aditxt common stock. These shares are reported as directly owned, giving investors a snapshot of this large shareholder’s current position.
Aditxt, Inc. reports an amendment to beneficial ownership by Tai Wey Ann. The amendment discloses 100,000 shares of Common Stock as beneficially owned, with the filing noting Ownership of 5 Percent or Less of a Class. The filing lists sole voting and dispositive power over 100,000 shares and provides Singapore residency details for the reporting person.
Aditxt, Inc. amendment to a Schedule 13G/A reports that Jonathan Edward Hester beneficially owns 0 shares of Common Stock (CUSIP 007025869), representing 0% of the class. The filing lists the reporting person's address and certifies ownership is five percent or less.
Aditxt, Inc. reports an amended Schedule 13G filing by Andy Ni stating zero beneficial ownership in its Common Shares (CUSIP 007025869). The amendment lists 0 shares and 0% ownership and affirms the filer holds voting and dispositive power of 0 shares.
Aditxt, Inc. received notice that a Nasdaq Hearings Panel has denied its request to remain listed, and its common stock will be suspended from trading on Nasdaq at the open on June 25, 2026, pending delisting.
The decision follows prior findings that Aditxt violated the minimum $1.00 bid price requirement for 30 consecutive business days and reported stockholders’ equity of $(35,174,386) as of March 31, 2026, far below the $2,500,000 Nasdaq equity requirement. The Panel also cited seven reverse stock splits, continued losses of about $5 million per quarter, and skepticism about a proposed $150 million SPAC transaction for its Ignite Proteomics subsidiary as reasons not to grant an exception.
Aditxt, Inc. ownership disclosure: Emil Cristian Burciu reports beneficial ownership of 45,000 shares of Common Stock, equal to 5.5% of the class as of 06/16/2026. The filing lists sole voting and sole dispositive power over those 45,000 shares.
The filing gives the issuer address as 737 N. Fifth Street, Suite 200, Richmond, Virginia. The statement is signed and dated 06/23/2026 by Emil Cristian Burciu as an individual reporting person.
Aditxt, Inc. insider Tai Wey Ann filed an initial Form 3, reporting beneficial ownership of 100,000 shares of Aditxt common stock. The filing identifies Tai Wey Ann as a ten percent owner. This Form 3 is a disclosure of existing holdings and does not report any new buy or sell transactions.
Aditxt, Inc. shareholder Tai Wey Ann reports beneficial ownership of 100,000 shares of Common Stock, representing 12.3% of the class.
The filing lists sole voting and sole dispositive power over the 100,000 shares. The form is signed on 06/23/2026 and references 06/16/2026 on the cover.